Kazarian Gregory N. 4/A

What Happened

• Gregory N. Kazarian, a director of P3 Health Partners, was granted 2,000 restricted stock units (RSUs) on August 6, 2025. Each RSU represents a right to one share of Class A common stock. The grant is reported at $0 (no purchase price); value will depend on the share price when/if the RSUs vest and convert to shares. This is an award/grant (transaction code A), not a purchase or sale.

Key Details

• Transaction date: August 6, 2025; Filing (amended): January 23, 2026 (Form 4 amended).
• Amount granted: 2,000 RSUs; reported acquisition price: $0.00.
• Vesting: RSUs vest upon the earlier of the Company’s 2026 annual stockholder meeting and the one-year anniversary of the grant date (per footnote).
• Amendment reason: The Form 4 was amended to correct the number of securities beneficially owned following the Company’s 1-for-50 reverse stock split effective April 11, 2025 (the amendment only corrects ownership reporting).
• Post-transaction total beneficial ownership is not specified in the data provided here; the amended filing corrects that figure on the official Form 4.

Context

• RSU grants are a common form of equity compensation for directors and employees; they do not involve an out‑of‑pocket purchase and only convert to shares if and when they vest.
• This filing is an amendment for reporting accuracy related to the reverse stock split, not an indication of additional trading activity.